MAPT and Alzheimer disease: New therapies should concentrate on increasing neuronal survival by avoiding the main mechanisms of cell death occurring in AD: hyperphosphorylation of the tau protein and formation of amyloid-β peptide aggregations (Aβ) [2,3].